Public Health - As enacted, adds as a disease for which a laboratory must test during a standard serological test of a pregnant woman hepatitis C antibody (anti-HCV) with automatic reflex to HCV RNA if anti-HCV is reactive, and makes certain other changes to the process of conducting required pregnancy serological tests. - Amends TCA Section 68-5-602.

This bill adds hepatitis C antibody (anti-HCV) testing to the standard blood screening required for all pregnant women in Tennessee during initial prenatal visits and between weeks 28-32 of pregnancy. If the anti-HCV test is reactive, labs must automatically conduct a follow-up HCV RNA test without requiring additional orders. It directly affects all pregnant women receiving routine prenatal care in Tennessee, expanding the required screening panel to include hepatitis C alongside existing tests for syphilis, rubella, and hepatitis B. The changes take effect July 1, 2025, and align hepatitis C testing protocols with existing disease reporting requirements for maternal health.